Low-T drugs marketed to help men get their mojo back are having a moment, but are they safe?
With the market for low-testosterone, or “Low-T,” therapy projected to reach $5 billion by 2017, many new centers have sprung up across the country offering a spectacular catch-all treatment.
TIME spoke to experts in the field and visited the Ageless Men’s Health testosterone clinic to get the inside story on a treatment that promises to “boost your strength training, sex drive and performance to the levels you’ve been wanting.”
Read TIME’s cover story, “Manopause?! Aging, Insecurity and the $2 Billion Testosterone Industry,” here.
Phillip Toledano for TIME
More Must-Reads From TIME
- What We Know So Far About the Deadly Earthquakes in Turkey and Syria
- Beyoncé's Album of the Year Snub Fits Into the Grammys' Long History of Overlooking Black Women
- How the U.S. Shot Down the Alleged Chinese Spy Balloon
- Effective Altruism Has a Toxic Culture of Sexual Harassment and Abuse, Women Say
- Inside Bolsonaro's Surreal New Life as a Florida Man—and MAGA Darling
- 'Return to Office' Plans Spell Trouble for Working Moms
- 8 Ways to Read More Books—and Why You Should
- Why Aren't Movies Sexy Anymore?
- How Logan Paul's Crypto Empire Fell Apart
